Tag: Asia Pacific
Lipaglyn (Saroglitazar) for Treating Hypertriglycerdemia in Type II Diabetes, India
Lipaglyn (Saroglitazar) is a dual peroxisome proliferator-activated receptor (PPAR) agonist indicated for the treatment of hypertriglyceridemia in Type II diabetics. The drug was discovered...
Halaven – Treatment of Metastatic Breast Cancer, Japan
Halaven is a non-taxane drug developed by Eisai Co. for the treatment of metastatic breast cancer. In March 2010, Eisai submitted a new drug...
Bayer seeks marketing authorisation of aflibercept solution for injection in Japan
Bayer Yakuhin has tendered a new application in Japan for marketing authorisation for its aflibercept solution for injection in the eye. The company submitted...
Jinan Asia Pharmaceutical Opens US Branch
Jinan Asia Pharmaceutical (JAP) opened an office in Irvine, California and introduced the newly formed HL-Pharma USA Corporation. JAP is one of the global...
Wockhardt Might Be Next Acquisition Target For US Pharmaceuticals
Wockhardt Limited, an Indian pharmaceutical and biotech firm, might be a good acquisition target amidst the rising trend of mergers and acquisitions (M&A) in...
Popular